Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Insulin pen
Pharma
Novo to gradually phase out production of human insulin pens
As sales of Novo Nordisk’s GLP-1 drugs continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities.
Fraiser Kansteiner
Nov 14, 2024 2:13pm
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
Nov 11, 2024 10:59am
Sanofi, Roche team up to drive adoption of smart insulin pen
Nov 8, 2021 7:50am
Cost for Lilly's generic insulin now 70% less than Humalog
Sep 28, 2021 9:35am
Walmart, with help from Novo Nordisk, offers discounted insulin
Jun 29, 2021 10:30am
Lilly amps Type 1 diabetes partnerships to reach more kids
Jan 28, 2021 10:30am
